Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma.

Ahmed I, Karedath T, Andrews SS, Al-Azwani IK, Mohamoud YA, Querleu D, Rafii A, Malek JA.

Oncotarget. 2016 Jun 14;7(24):36366-36381. doi: 10.18632/oncotarget.8917.

2.

Deciphering the molecular nature of ovarian cancer biomarker CA125.

Weiland F, Martin K, Oehler MK, Hoffmann P.

Int J Mol Sci. 2012;13(8):10568-82. doi: 10.3390/ijms130810568. Epub 2012 Aug 22. Review.

3.

Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.

Raamanathan A, Simmons GW, Christodoulides N, Floriano PN, Furmaga WB, Redding SW, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2012 May;5(5):706-16. doi: 10.1158/1940-6207.CAPR-11-0508. Epub 2012 Apr 9.

4.

Lactobacillus adhesion to mucus.

Van Tassell ML, Miller MJ.

Nutrients. 2011 May;3(5):613-36. doi: 10.3390/nu3050613. Epub 2011 May 20. Review.

5.

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors.

Yu Y, Edassery SL, Barua A, Abramowicz JS, Bahr JM, Hellstrom I, Luborsky JL.

J Ovarian Res. 2011 Jul 29;4:12. doi: 10.1186/1757-2215-4-12.

6.

E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.

Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM, Hales DB.

Gynecol Oncol. 2009 Jun;113(3):362-9. doi: 10.1016/j.ygyno.2009.02.011. Epub 2009 Mar 24.

Supplemental Content

Support Center